Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well
Improves metabolism Supports long-term fat reduction and better energy balance
Dehydration related to vomiting can lead to health problems like kidney failure
Your body was just getting comfortable at the lower dose, and now you are asking it to handle twice as much
Use a simple log: note carbs eaten, time, and morning breath score for one week
thus, GLP-1 RAs may serve as valuable tools in preoperative risk reduction [102, 103]